Jürgen Erbe

Schultze & Braun: Dr. Jürgen Erbe secures future of Heidelberg clinic proaesthetic

View on LinkedIn – see current LinkedIn likes

Insolvency administrator Dr. Jürgen Erbe of Schultze & Braun has secured the future of the Heidelberg clinic for plastic and cosmetic surgery proaesthetic GmbH, the firm announced on 12 October 2026. Central Aesthetics took over the business operations as of 1 October 2026; the contracts have been signed.

Jürgen Erbe
Jürgen Erbe

According to the firm, almost all of the clinic’s more than 30 employees were taken over, and the business will remain at its known address in Heidelberg. Patient care was ensured throughout the process, as the transfer was carried out during ongoing clinic operations.

Improving law firms’ results in
Chambers and Co. since 2004.
200+ law firms advised worldwide.
Customers include Eversheds, Freshfields, Taylor Wessing and others.
Learn more

Law Business

Dr. Jürgen Erbe said he was very pleased to have found in Central Aesthetics a buyer from the industry that brings the necessary know-how and fits the range of services and strategic orientation of proaesthetic. Sandro Stroh, managing director of Central Aesthetics, said proaesthetic fits optimally into its portfolio.

Proaesthetic has been providing medical services in plastic, aesthetic and cosmetic surgery as well as minimally invasive aesthetic medicine since 1993.

For detailed information, as well as the picture copyright, please see the law firm’s original article here: https://www.schultze-braun.de/news/aus-proaesthetic-wird-central-aesthetics-dr-juergen-erbe-sichert-zukunft-von-heidelberger-schoenheitsklinik

More news

Trending news

Adrien de Hauteclocque has joined Geradin Partners as Senior Counsel in its Paris and Brussels offices, the firm announced on [...]
Chammas & Marcheteau has advised Amundi Private Equity Funds on its investment in Groupe Cap Vert, alongside majority shareholder Gimv [...]
Occhiuto Legal has advised Rulen and its founders Simone Hong and Claudio Cama on a EUR 1.8 million capital increase, [...]